NCT02725437 Clostridium Difficile Vaccine Safety, Tolerability, and Immunogenicity Study in Japanese Adults Status COMPLETED Phase PHASE1
NCT02725411 Long Term Safety and Efficacy Study of Tanezumab in Japanese Adult Subjects With Chronic Low Back Pain Status COMPLETED Phase PHASE3
NCT02724163 International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia Status RECRUITING Phase PHASE3
NCT02720874 Multidisciplinary Approach for Treat To Target In Rheumatoid Arthritis Status WITHDRAWN Phase NA
NCT02718677 Patient-reported Outcomes in Subjects Treated With ReFacto AF Routine Prophylaxis Status WITHDRAWN Phase N/A
NCT02718417 Avelumab in Previously Untreated Patients With Epithelial Ovarian Cancer (JAVELIN OVARIAN 100) Status TERMINATED Phase PHASE3
NCT02713763 Efficacy of Rechallenge With Sunitinib in Metastatic Pancreatic Neuroendocrine Tumor Previously Failed to Sunitinib Status COMPLETED Phase PHASE2
NCT02711462 Study in Healthy Subjects to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06687234 Status TERMINATED Phase PHASE1
NCT02709486 Study of the Analgesic Efficacy and Safety of Subcutaneous Tanezumab in Subjects With Osteoarthritis of the Hip or Knee. Status COMPLETED Phase PHASE3
NCT02708355 Pilot Study To Investigate The Association Between Acid Control And Heartburn Symptoms After Proton Pump Inhibitor Treatment Status COMPLETED Phase PHASE4
NCT02697864 A Study Comparing Amounts of Tafamidis In The Blood Without Food Status COMPLETED Phase PHASE1
NCT02697773 Efficacy and Safety of a Subcutaneous Tanezumab Titration Dosing Regimen in Subjects With Moderate to Severe Osteoarthritis of the Hip or Knee Status COMPLETED Phase PHASE3
NCT02693535 TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer Status RECRUITING Phase PHASE2
NCT02689167 Study to Assess Various Sunitinib Schedules in Renal Cell Carcinoma Status UNKNOWN Phase PHASE2
NCT02687542 Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations Status TERMINATED Phase PHASE2
NCT02687191 Safety and Tolerability of PF-05230907 in Intracerebral Hemorrhage Status TERMINATED Phase PHASE1
NCT02684006 A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101) Status COMPLETED Phase PHASE3
NCT02680847 Safety and Pharmacokinetic Study of ALO-02 in Children Ages 7-17 With Pain Status TERMINATED Phase PHASE4